SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001214659-14-001324
Filing Date
2014-02-20
Accepted
2014-02-20 13:43:01
Documents
1
Group Members
BIOVISION LIFE SCIENCE FUND NO.1SBI BB MEDIA INVESTMENT LIMITED PARTNERSHIPSBI BB MOBILE INVESTMENT LPSSBI BIO LIFE SCIENCE INVESTMENT LPSSBI BROADBAND FUND NO. 1 LIMITED PARTNERSHIPSBI CAPITAL MANAGEMENT CO. LTD.SBI INCUBATION CO. LTD.SBI INVESTMENT CO.

Document Format Files

Seq Description Document Type Size
1 j218140sc13d.htm SC 13D 541364
  Complete submission text file 0001214659-14-001324.txt   543684
Mailing Address 1301 SECOND AVE. SUITE 1900 SEATTLE WA 98101
Business Address 1301 SECOND AVE. SUITE 1900 SEATTLE WA 98101 206-805-8300
ACUCELA INC. (Subject) CIK: 0001400482 (see all company filings)

IRS No.: 020592619 | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-88011 | Film No.: 14628695
SIC: 2834 Pharmaceutical Preparations

Mailing Address IZUMI GARDEN TOWER 19F, 1-6-1 ROPPONGI MINATO-KU TOKYO M0 106-6019
Business Address IZUMI GARDEN TOWER 19F, 1-6-1 ROPPONGI MINATO-KU TOKYO M0 106-6019 81-3-6229-0122
SBI Holdings, Inc. (Filed by) CIK: 0001446698 (see all company filings)

IRS No.: 000000000 | State of Incorp.: M0 | Fiscal Year End: 0331
Type: SC 13D